Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
T-box transcription factor 20 is a protein encoded by the TBX20 gene located on chromosome 7q14.2. It contains a highly conserved T-box DNA-binding domain and functions as a key regulator of multiple cardiac genes through interaction with other cardiac transcription factors such as NKX2-5 and GATA4. TBX20 coordinates cell proliferation, differentiation, and morphogenesis during embryonic heart development, including the formation of heart chambers and valves. Mutations in TBX20 are strongly associated with a spectrum of congenital heart defects, such as atrial septal defect, and with cardiac dysfunction in adulthood, including dilated cardiomyopathy and arrhythmias. TBX20’s broad influence on cardiac gene networks makes it a focus of research in cardiovascular development, disease pathogenesis, and potentially therapeutic gene modulation.
No small molecules or therapies with characterized mechanism of action targeting TBX20, but gene therapy or transcriptional modulation are theoretical approaches.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on T-box transcription factor 20 (TBX20).